A Randomized, Open-label, Active-Controlled and Blinded-Endpoint Trial Comparing the Antiplatelet Effects of Ticagrelor Plus Aspirin Versus Clopidogrel Plus Aspirin in Chinese Patients With High-risk Transient Ischemic Attack or Minor Stroke.
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Stroke
- Focus Pharmacodynamics
- Acronyms PRINCE
- 11 Dec 2017 Planned End Date changed from 14 Mar 2018 to 10 Mar 2018.
- 11 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2017 Planned End Date changed from 1 Oct 2016 to 14 Mar 2018.